ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
98 301,95
0,20%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. CollPlant Biotechnologies Ltd (CLGN) Cours

CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd (CLGN)

NASDAQ
4,218
0,408
(10,71%)
Fermé 04 Janvier 10:00PM
Retardé de 15 minutes
4,218
0,00
(0,00%)
Après les heures de négociation: 10:06PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
4,218
Prix Achat
2,94
Prix Vente
17,35
Volume échangé
5 563
3,86 Fourchette du Jour 4,22
3,24 Plage de 52 semaines 6,75
Cap du marché
48,307M
Clôture Veille
3,81
Ouverture
3,86
Dernière Transaction
8
@
4.23
Dernière heure de transaction
Volume financier
US$ 22 900
VWAP
4,1165
Volume moyen (3 m)
14 690
Actions en circulation
11 452 672
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,89
Bénéfice par action (BPA)
-0,61
Chiffre d'affairess
10,96M
Bénéfice net
-7,02M

À propos de CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technolog... CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. Show more

Secteur
Medicinal Chems,botanicl Pds
Industrie
Real Estate
Site Web
www.collplant.com
Siège social
Rehovot, Center, Isr
Fondé
1981
CollPlant Biotechnologies Ltd est coté dans le secteur Medicinal Chems,botanicl Pds de la NASDAQ avec le ticker CLGN. Le dernier cours de clôture d'CollPlant Biotechnologies était de US$3,81. Au cours de la dernière année, les actions de CollPlant Biotechnologies ont été négociées dans une fourchette de prix de US$ 3,24 à US$ 6,75.

CollPlant Biotechnologies compte actuellement 11 452 672 actions en circulation. La capitalisation boursière d'CollPlant Biotechnologies est de US$43,63 million. CollPlant Biotechnologies a un ratio cours/bénéfice (ratio PE) de -6.89.

CLGN Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

27 Novembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

25 Septembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 Août 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 Août 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

19 Août 2024
Edgar (US Regulatory)

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants PR Newswire REHOVOT, Israel & EDEN PRAIRIE, Minn., Aug. 19, 2024 3D Printed Breast...

19 Août 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

29 Juillet 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 Juin 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

29 Mai 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 Février 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.509613.74177542883.70844.2183.3854146843.61051655CS
40.31678.117806884883.90134.2183.24160793.67047527CS
12-0.382-8.304347826094.64.993.24146903.92415902CS
26-0.762-15.30120481934.985.483.24130774.31847763CS
52-1.922-31.30293159616.146.753.24105474.73347304CS
156-12.082-74.122699386516.316.823.24183587.925212CS
260-1.582-27.2758620695.824.263.242867712.45893182CS

CLGN - Frequently Asked Questions (FAQ)

What is the current CollPlant Biotechnologies share price?
The current share price of CollPlant Biotechnologies is US$ 4,218
How many CollPlant Biotechnologies shares are in issue?
CollPlant Biotechnologies has 11 452 672 shares in issue
What is the market cap of CollPlant Biotechnologies?
The market capitalisation of CollPlant Biotechnologies is USD 43,63M
What is the 1 year trading range for CollPlant Biotechnologies share price?
CollPlant Biotechnologies has traded in the range of US$ 3,24 to US$ 6,75 during the past year
What is the PE ratio of CollPlant Biotechnologies?
The price to earnings ratio of CollPlant Biotechnologies is -6,89
What is the cash to sales ratio of CollPlant Biotechnologies?
The cash to sales ratio of CollPlant Biotechnologies is 4,41
What is the reporting currency for CollPlant Biotechnologies?
CollPlant Biotechnologies reports financial results in USD
What is the latest annual turnover for CollPlant Biotechnologies?
The latest annual turnover of CollPlant Biotechnologies is USD 10,96M
What is the latest annual profit for CollPlant Biotechnologies?
The latest annual profit of CollPlant Biotechnologies is USD -7,02M
What is the registered address of CollPlant Biotechnologies?
The registered address for CollPlant Biotechnologies is 4 OPPENHEIMER, WEIZMANN SCIENCE PARK, P.O.B 4132, REHOVOT, CENTER, 7670104
What is the CollPlant Biotechnologies website address?
The website address for CollPlant Biotechnologies is www.collplant.com
Which industry sector does CollPlant Biotechnologies operate in?
CollPlant Biotechnologies operates in the REAL ESTATE sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
259,78M
NITON2OFF Inc
US$ 2,6306
(145,85%)
350,92M
CRNCCerence Inc
US$ 19,33
(143,76%)
159,55M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,78M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,59M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
155,16k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
967,95k
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,4M
NITON2OFF Inc
US$ 2,6306
(145,85%)
350,92M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
330,82M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,59M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
259,78M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
222,72M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CLGN
CollPlant Biotechnologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés